share_log

8-K: Current report

8-K: Current report

8-K：重大事件
美股SEC公告 ·  06/07 17:28
Moomoo AI 已提取核心信息
SeaStar Medical Holding Corporation, a medical device company, has announced the completion of a 25-for-1 reverse stock split, effective as of 5:00 p.m. EDT on June 7, 2024. The reverse stock split was previously approved by the company's stockholders during a Special Meeting on September 6, 2023. Trading on a split-adjusted basis will commence on the Nasdaq Capital Market under the existing ticker symbol 'ICU' starting June 10, 2024. The reverse split aims to increase the market price of SeaStar Medical's common stock to meet Nasdaq's minimum bid price requirement. Post-split, the company will have approximately 3.1 million shares of common stock issued and outstanding. The company's transfer agent, Colonial Stock Transfer Company, Inc., will act as the exchange agent for...Show More
SeaStar Medical Holding Corporation, a medical device company, has announced the completion of a 25-for-1 reverse stock split, effective as of 5:00 p.m. EDT on June 7, 2024. The reverse stock split was previously approved by the company's stockholders during a Special Meeting on September 6, 2023. Trading on a split-adjusted basis will commence on the Nasdaq Capital Market under the existing ticker symbol 'ICU' starting June 10, 2024. The reverse split aims to increase the market price of SeaStar Medical's common stock to meet Nasdaq's minimum bid price requirement. Post-split, the company will have approximately 3.1 million shares of common stock issued and outstanding. The company's transfer agent, Colonial Stock Transfer Company, Inc., will act as the exchange agent for the reverse stock split. Stockholders holding shares through banks, brokers, or nominees will see their holdings automatically adjusted to reflect the reverse stock split. Additionally, the company filed the Second Certificate of Amendment to its Certificate of Incorporation with the Delaware Department of State, which became effective on the same day as the reverse split.
医疗器械公司SeaStar Medical Holding Corporation宣布完成25比1的反向股票拆分，自2024年6月7日下午5点EDT起生效。反向股票拆分于2023年9月6日的特别会议上获得股东批准。股票在拆分调整的基础上交易，自2024年6月10日起在纳斯达克资本市场上以现有 逐笔明细代码'ICU'开盘。反向拆分的目的是将SeaStar Medical的普通股市场价格提高到达到纳斯达克的最低买盘价格要求。拆分后，公司将发行约310万股普通股。公司的转让代理商Colonial 股份转让公司将担任反向股票拆分的交易所代理商。通过银行、经纪人或投票人持有股票的股东将自动调整其持有股份以反映反向股票拆分。此外，该公司向特拉华州国务院提交了第二次修订公司章程的证书，并于同一天生效。
医疗器械公司SeaStar Medical Holding Corporation宣布完成25比1的反向股票拆分，自2024年6月7日下午5点EDT起生效。反向股票拆分于2023年9月6日的特别会议上获得股东批准。股票在拆分调整的基础上交易，自2024年6月10日起在纳斯达克资本市场上以现有 逐笔明细代码'ICU'开盘。反向拆分的目的是将SeaStar Medical的普通股市场价格提高到达到纳斯达克的最低买盘价格要求。拆分后，公司将发行约310万股普通股。公司的转让代理商Colonial 股份转让公司将担任反向股票拆分的交易所代理商。通过银行、经纪人或投票人持有股票的股东将自动调整其持有股份以反映反向股票拆分。此外，该公司向特拉华州国务院提交了第二次修订公司章程的证书，并于同一天生效。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

独立文件3  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息